CCOC(=O)NC(=O)c1cn(CC(=O)NCC(=O)NCC(=O)N2CCN(CCn3c(C)nc(C(N)=O)c3N)CC2)c(=O)[nH]c1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?